Matt Campobasso - Enfusion General Counsel
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
Executive
Matt Campobasso is General Counsel of Enfusion
| Phone | 312 253 9800 |
| Web | https://www.enfusion.com |
Matt Campobasso Latest Insider Activity
Tracking and analyzing the buying and selling activities of Matt Campobasso against Enfusion stock is an integral part of due diligence when investing in Enfusion. Matt Campobasso insider activity provides valuable insight into whether Enfusion is net buyers or sellers over its current business cycle. Note, Enfusion insiders must abide by specific rules, including filing SEC forms every time they buy or sell Enfusion'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Matt Campobasso over a year ago Disposition of 493 shares by Matt Campobasso of Enfusion at 8.95 subject to Rule 16b-3 |
Enfusion Management Efficiency
The company has return on total asset (ROA) of 0.0305 % which means that it generated a profit of $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0442 %, meaning that it created $0.0442 on every $100 dollars invested by stockholders. Enfusion's management efficiency ratios could be used to measure how well Enfusion manages its routine affairs as well as how well it operates its assets and liabilities.Enfusion currently holds 20.31 M in liabilities. Enfusion has a current ratio of 8.99, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Enfusion's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Nandan Amladi | Meridianlink | N/A | |
| Elizabeth Rieveley | Meridianlink | N/A | |
| Damian JD | PROS Holdings | 50 | |
| Prasad Ramakrishnan | Freshworks | N/A | |
| Shannon Tatz | PROS Holdings | N/A | |
| Susan Bennett | E2open Parent Holdings | 58 | |
| Tessa Barron | ON24 Inc | N/A | |
| Catherine LaCour | Blackbaud | N/A | |
| Nicole McGougan | Blackbaud | N/A | |
| Johanna Jackman | Freshworks | N/A | |
| Brian Wheeler | Braze Inc | N/A | |
| Callan Young | ON24 Inc | N/A | |
| Doug Piper | Meridianlink | N/A | |
| May ONeal | ON24 Inc | N/A | |
| Susan Garcia | CS Disco LLC | 53 | |
| Priyanka Singh | Braze Inc | 56 | |
| Craig Zawada | PROS Holdings | 54 | |
| Joon JD | Clearwater Analytics Holdings | N/A | |
| Gregory Randolph | E2open Parent Holdings | 55 | |
| Jesse Hoobler | Braze Inc | N/A | |
| Pawan Joshi | E2open Parent Holdings | 53 | |
Management Performance
| Return On Equity | 0.0442 | |||
| Return On Asset | 0.0305 |
Enfusion Leadership Team
Elected by the shareholders, the Enfusion's board of directors comprises two types of representatives: Enfusion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enfusion. The board's role is to monitor Enfusion's management team and ensure that shareholders' interests are well served. Enfusion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enfusion's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Dorton, Chief Officer | ||
| Michael Berry, Chief Officer | ||
| Lorelei Skillman, Chief Officer | ||
| Vivek Ranka, Head Technology | ||
| Stephen Malherbe, Managing Partner | ||
| Oleg Movchan, Interim Director | ||
| Matthew Campobasso, General Secretary | ||
| Bronwen Bastone, Chief Officer | ||
| Joseph Defeo, Global Production | ||
| Lotte Tonsberg, Head EMEA | ||
| Kabir Kohli, MD Services | ||
| Jeff Young, Head Implementation | ||
| Iris Wang, Chief Officer | ||
| Brian Murphy, Investor | ||
| Matt Campobasso, General Counsel | ||
| Robert Taylor, Head Support | ||
| Ignatius Njoku, Head Relations | ||
| Bradley Herring, Chief Officer | ||
| Neal Pawar, Chief Officer | ||
| Daniel Groman, Chief Officer | ||
| Valeria Gutowski, Chief Officer |
Enfusion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Enfusion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0442 | |||
| Return On Asset | 0.0305 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.01 B | |||
| Shares Outstanding | 94.8 M | |||
| Shares Owned By Insiders | 4.73 % | |||
| Shares Owned By Institutions | 96.25 % | |||
| Number Of Shares Shorted | 1.3 M | |||
| Price To Earning | 0.11 X |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |